Abstract
Transcranial sonography (TCS) is a valuable tool in the diagnosis of Parkinson’s disease (PD). However, substantia nigra hyperechogenicity (SN+) in TCS has been shown to be also evident in about 8–10% of healthy persons. Neuroimaging studies and slight motor deficits in subjects with SN+ indicate functional impairment of the nigrostriatal system associated with the ultrasound sign. We questioned, whether SN+ may also be associated with neuropsychological deficits and whether there is a relation to other PD premotor markers. Thirty-six subjects with SN+ and 34 control persons (SN−) older than 50 years were investigated. The delayed verbal memory recall (LogII) of subjects with SN+ was significantly reduced compared to the performance of the control group (P = 0.02). Binary logistic regression analysis revealed that, besides UPDRS-III (P < 0.001) and positive family history for PD (P < 0.01), LogII (P < 0.05) seems to be independently associated with SN+.
Similar content being viewed by others
References
Baeumler G (1985) Farb-Wort-Interferenztest nach J.R. Stroop (FWIT). Hogrefe, Goettingen
Behnke S, Double KL, Duma S, Broe GA, Guenther V, Becker G et al (2007) Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 34:1054–1059
Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC et al (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50:34–41
Berg D (2006) Marker for a preclinical diagnosis of Parkinson’s disease as a basis for neuroprotection. J Neural Transm 71(Suppl):1–10
Berg D (2008) Biomarkers for the early detection of Parkinson’s and Alzheimer’s disease. Neurodegen Dis 5:133–136
Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M et al (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031
Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G (2001a) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463–467
Berg D, Siefker C, Ruprecht-Dorfler P, Becker G (2001b) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56:13–17
Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P et al (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999–1005
Daum RF, Sekinger B, Kobal G, Lang CJ (2000) Olfactory testing with “sniffin’ sticks” for clinical diagnosis of Parkinson disease. Nervenarzt 71:643–650
Dujardin K, Duhamel A, Becquet E, Grunberg C, Defebvre L, Destee A (1999) Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:323–328
Fearnley JM, Lees AJ (1990) Striatonigral degeneration. A clinicopathological study. Brain 113:1823–1842
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 22:839–842
Haerting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J (2000) Wechsler Gedächtnistest-Revidierte Fassung Deutsche Adaptation der revidierten Fassung der Wechlser Memory Scale. Huber, Bern
Hawkes C (2006) Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 63:133–151
Hautzinger M, Bailer M, Worall H, Keller F (1995) Becks-depressions-inventar (BDI), 2 edn. Huber, Bern
Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bonner J et al (1994) Discordant twins with Parkinson’s disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 36:176–182
Kessler J, Denzler P, Markowitsch HJ (1988) Demenz-Test. Beltz, Weinheim
Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM et al (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211
Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992) L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 107:394–404
Leentjens AF, Van den AM, Metsemakers JF, Lousberg R, Verhey FR (2003) Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18:414–418
Lewis SJ, Slabosz A, Robbins TW, Barker RA, Owen AM (2005) Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson’s disease. Neuropsychologia 43:823–832
Memory Clinic-NPZ (2005) The consorium to establish a registry of Alzheimer’s Disease CERAD-Plus. Memory Clinic-NPZ, Basel
Muller U, Wachter T, Barthel H, Reuter M, von Cramon DY (2000) Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson’s disease. J Neural Transm 107:303–319
Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245
Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA (2005) A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28:216–226
Ruprecht-Dorfler P, Klotz P, Becker G, Berg D (2006) Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 13:362–364
Schweitzer KJ, Behnke S, Liepelt I, Wolf B, Grosser C, Godau J et al (2007) Cross-sectional study discloses a positive family history for Parkinson’s disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm 114(9):1167–1171
Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J et al (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19:1196–1202
Sturm W, Willmes K, Horn W (1993) Leistungspruefsystem fuer 50–90jaehrige (LPS 50+). Hogrefe, Goettingen
Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson’s disease. The cortical focus of neostriatal outflow. Brain 109:845–883
Tewes U (1991) HAWIE-R: Hamburg-Wechsler-Intelligenztest fuer Erwachsene, revision 1991. Huber, Bern
Tucha O, Lange KW (2004) The tower of London—German version. Hogrefe, Göttingen
Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS et al (1998) Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155:344–349
Zimmermann P, Fimm B (2002) Testbatterie zur Aufmerksamkeitsprüfung (Version 1.7). Psytests, Herzogenrath
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liepelt, I., Wendt, A., Schweitzer, K.J. et al. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population. J Neural Transm 115, 993–999 (2008). https://doi.org/10.1007/s00702-008-0043-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-008-0043-6